Patent News

Pyrazolo[4,3-<i>H</i>]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer

Author(s):

Surya K. De*   Pages 1040 - 1043 ( 4 )

Abstract:

The application describes the synthesis of 1H-pyrazolo[4,3-H]quinazoline compounds for treating cell proliferation dysfunction and is a broad-spectrum and strongly- active inhibitor for a cell cyclin-dependent kinase (CDK).

Keywords:

: Pyrazolo-quinazoline, cyclin-dependent kinase, cancer, inflammation, cell-cycle regulation, cell proliferation.

Affiliation:

Read Full-Text article